- Global Pharma News & Resources

Drägerwerk AG & Co. KGaA: Dräger terminates series D participation certificates

Drägerwerk AG & Co. KGaA / Key word(s): Corporate Action
Drägerwerk AG & Co. KGaA: Dräger terminates series D participation certificates

24-March-2020 / 15:24 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Drägerwerk AG & Co. KGaA decided today to terminate all 566,819 series D participation certificates (Genussscheine) (ISIN DE0005550719) in accordance with Section 6 (3) of their terms and conditions giving 24 months' notice as of the end of calendar year 2022. The termination will be published in the next few days in accordance with Section14 (1) of their terms and conditions in the German Federal Gazette (Bundesanzeiger).

The buyback value is calculated pursuant to Section 12 (2) and (3) of the terms and conditions of the participation certificates and is equivalent to ten times the average stock market price of the preferred shares (Vorzugsaktien) over the three calendar months prior to the announcement of the termination (December 2019 to February 2020). The buyback value amounts to approximately EUR 310 million. The payment of the buyback value to the holders of the participation certificates will be made in January 2023 in accordance with Section 6 (7) of the terms and conditions.

Dräger is planning the payment from existing liquidity. It has sufficient credit lines if required.

Drägerwerk AG & Co. KGaA
Moislinger Allee 53-55
23558 Lübeck, Deutschland

Investor Relations:
Thomas Fischler
Tel. +49 451 882-2685

Corporate Communications:
Melanie Kamann
Tel. +49 451 882-3202

This ad hoc report contains statements on the future development of Dräger Group. These forward-looking statements are based on the current expectations, presumptions, and forecasts of the Executive Board as well as the information available to date. They were compiled to the best of the company's knowledge. Dräger does not provide any warranty nor assume any responsibility for the future developments and results described above. These are dependent on a number of factors. They entail various risks and contingencies outside of the company's influence and are based on assumptions which could prove to be incorrect. Dräger does not assume any responsibility for updating the forward-looking statements contained in this report. This does not infringe any legal stipulations on the adjustment of forecasts. Please go to Investor Relations / Definitions of financial indicators at for information on alternative performance measures used.

24-March-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at

Language: English
Company: Drägerwerk AG & Co. KGaA
Moislinger Allee 53-55
23542 Lübeck
Phone: +49 (0)451 882-0
Fax: +49 (0)451 882-2080
ISIN: DE0005550602, DE 000 555 063 6, DE 000 555 065 1, DE 000 555 067 7, DE 000 555 071 9
WKN: 555060, 555063 Vorzüge, 555065 Genussschein A, 555067 Genussschein K, 555071 Genussschein D
Indices: SDAX, TecDAX
Listed: Regulated Market in Berlin, Dusseldorf, Frankfurt (Prime Standard), Hamburg, Hanover, Munich; Regulated Unofficial Market in Stuttgart, Tradegate Exchange
EQS News ID: 1005699

End of Announcement DGAP News Service

Editor Details

Last Updated: 24-Mar-2020